{"id":3923,"date":"2016-04-15T08:09:40","date_gmt":"2016-04-15T08:09:40","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/"},"modified":"2016-04-15T08:09:40","modified_gmt":"2016-04-15T08:09:40","slug":"nanexa-offentliggor-prospekt","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-offentliggor-prospekt\/","title":{"rendered":"Nanexa offentligg\u00f6r prospekt"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span><em>Prospektet avseende f\u00f6retr\u00e4desemission i Nanexa AB (publ) har godk\u00e4nts och registrerats av Finansinspektionen och finns nu tillg\u00e4ngligt p\u00e5 bolagets hemsida www.nanexa.com.<\/em><\/span><\/p>\n<\/p>\n<p><span>Aktie\u00e4gare vars innehav \u00e4r direktregistrerat i Euroclear Sweden AB p\u00e5 avst\u00e4mningsdagen den 20 april 2016 kommer att f\u00e5 en f\u00f6rtryckt emissionsredovisning med inbetalningskort samt en sammanfattning av erbjudandet per post till den i Euroclear angivna adressen. Aktie\u00e4gare som har sitt innehav i aktiedep\u00e5 eller p\u00e5 annat s\u00e4tt f\u00f6rvaltat genom f\u00f6rvaltare f\u00e5r information och instruktioner direkt fr\u00e5n sin bank eller f\u00f6rvaltare. Prospektet kommer att finnas tillg\u00e4ngligt p\u00e5 Nanexas hemsida, www.nanexa.com, p\u00e5 emissionsinstitutets hemsida <a href=\"http:\/\/www.eminova.se\/\" rel=\"nofollow\"><span>www.eminova.se<\/span><\/a>, p\u00e5 Redeyes hemsida, <a href=\"http:\/\/www.redeye.se\/\" rel=\"nofollow\"><span>www.redeye.se<\/span><\/a> samt \u00e4ven p\u00e5 AktieTorgets hemsida, www.aktietorget.se.<\/span><\/p>\n<\/p>\n<p><span>Teckningstiden i f\u00f6retr\u00e4desemissionen l\u00f6per fr\u00e5n den 25 april till och med den 13 maj 2016. De som p\u00e5 avst\u00e4mningsdagen \u00e4r aktie\u00e4gare i Nanexa erh\u00e5ller en (1) teckningsr\u00e4tt per aktie och tv\u00e5 (2) teckningsr\u00e4tter ger r\u00e4tt att teckna en (1) ny aktie i bolaget till kursen 8,00 kronor per aktie. H\u00e4rut\u00f6ver erbjuds aktie\u00e4gare och andra investerare att utan f\u00f6retr\u00e4desr\u00e4tt anm\u00e4la intresse om teckning av nya aktier. F\u00f6retr\u00e4desemissionen t\u00e4cks till cirka 70 procent av garanti\u00e5taganden och teckningsf\u00f6rbindelser.<\/span><\/p>\n<\/p>\n<p><span>F\u00f6r mer information kontakta:<\/span><\/p>\n<\/p>\n<p><span>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/span><\/p>\n<\/p>\n<p><span>?Telefon: 0709 -42 83 03?<\/span><\/p>\n<\/p>\n<p><span>E-post:\u00a0david.westberg@nanexa.se<\/span><\/p>\n<\/p>\n<p><span><a href=\"http:\/\/www.nanexa.se\/\" rel=\"nofollow\">www.nanexa.se<\/a><\/span><\/p>\n<\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<\/p>\n<p><span>Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Karolinska Institutet.<\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/aktietorget.blob.core.windows.net\/press\/news\/nanexa\/77826\/501537.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p><em>Prospektet avseende f\u00f6retr\u00e4desemission i Nanexa AB (publ) har godk\u00e4nts och registrerats av Finansinspektionen och finns nu tillg\u00e4ngligt p\u00e5 bolagets hemsida www.nanexa.com.<\/em><\/p>\n<p>Aktie\u00e4gare vars innehav \u00e4r direktregistrerat i Euroclear Sweden AB p\u00e5 avst\u00e4mningsdagen den 20 april 2016 kommer att f\u00e5 en f\u00f6rtryckt emissionsredovisning med inbetalningskort samt en sammanfattning av erbjudandet per post till den i Euroclear angivna adressen.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-offentliggor-prospekt\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3923","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ca-prospectus_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa offentligg\u00f6r prospekt - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa offentligg\u00f6r prospekt - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Prospektet avseende f\u00f6retr\u00e4desemission i Nanexa AB (publ) har godk\u00e4nts och registrerats av Finansinspektionen och finns nu tillg\u00e4ngligt p\u00e5 bolagets hemsida www.nanexa.com. Aktie\u00e4gare vars innehav \u00e4r direktregistrerat i Euroclear Sweden AB p\u00e5 avst\u00e4mningsdagen den 20 april 2016 kommer att f\u00e5 en f\u00f6rtryckt emissionsredovisning med inbetalningskort samt en sammanfattning av erbjudandet per post till den i Euroclear angivna adressen.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-offentliggor-prospekt\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-offentliggor-prospekt\\\/\",\"name\":\"Nanexa offentligg\u00f6r prospekt - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-04-15T08:09:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-offentliggor-prospekt\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-offentliggor-prospekt\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-offentliggor-prospekt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa offentligg\u00f6r prospekt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa offentligg\u00f6r prospekt - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa offentligg\u00f6r prospekt - Nanexa AB","og_description":"Prospektet avseende f\u00f6retr\u00e4desemission i Nanexa AB (publ) har godk\u00e4nts och registrerats av Finansinspektionen och finns nu tillg\u00e4ngligt p\u00e5 bolagets hemsida www.nanexa.com. Aktie\u00e4gare vars innehav \u00e4r direktregistrerat i Euroclear Sweden AB p\u00e5 avst\u00e4mningsdagen den 20 april 2016 kommer att f\u00e5 en f\u00f6rtryckt emissionsredovisning med inbetalningskort samt en sammanfattning av erbjudandet per post till den i Euroclear angivna adressen.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/","name":"Nanexa offentligg\u00f6r prospekt - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-04-15T08:09:40+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-offentliggor-prospekt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa offentligg\u00f6r prospekt"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}